Previous 10 | Next 10 |
home / stock / bayry / bayry news
This article is the fourth in a series designed to help investors decide for themselves if Jeremy Grantham's "epic bubble" call is correct. In this analysis, 129 of the 180 largest holdings of the Vanguard Total International ETF are put under the valuation microscope. These 129 I...
Stocks finished the year strongly with cyclicals and energy stocks rallying strongly. I am continuing my monthly investment plans while awaiting a market correction or possibly a real crash once market euphoria has come down. My dividend income amounted to $379, up 30% sequentiall...
The time has come to look what we might want to look at as appealing investments going into February of 2021. We look at the areas of Financials, Real Estate, Industrials, IT and Pharma/Healthcare. Ongoing rising valuations make continued caution a necessity. Know your price targe...
Mittleman Investment Management, LLC is an SEC-registered investment adviser that provides discretionary portfolio management to institutional investors and high-net-worth individuals. Mittleman Investment Management, LLC’s composite gained 31.0% net of fees in the fourth quart...
On January 13, ESSA announced a collaboration agreement with Janssen to evaluate ESSA's EPI-7386 in combo with Janssen's apalutamide and in combo with abiraterone acetate plus prednisone in patients with mCRPC. EPI-7386 is a novel approach to treat prostate cancer by targeting the N-t...
Many stocks are in a bubble and extremely overvalued. While it seems easy to decide in which stocks not to invest, it is much more difficult to find good picks in this market driven by irrational exuberance. Finding recession-proof companies is a good starting point, but the stock...
The time has come for us to look at just what sort of companies may be appealing to invest in during January of 2021. We look at the areas of Financials, Real Estate, Industrials, IT and Pharma/Healthcare. The ongoing records in the market has caused many of our previously-apparen...
The FDA approves Merck's (MRK) Verquvo, a soluble guanylate cyclase (sGC) stimulator, to reduce the risk of cardiovascular death and heart failure following hospitalization or need for outpatient intravenous diuretics in adults with chronic heart failure and ejection fraction less than 4...
Bayer (BAYRY) is considering expanding its agreement with CureVac (CVAC) to include the production of German biopharmaceutical company’s coronavirus vaccine candidate CVnCoV, reports Welt am Sonntag.In an interview with the German newspaper, the CEO of Bayer, Werner Baum...
Stocks finished the year strongly with cyclicals and energy stocks rallying strongly. I am continuing my monthly investment plans and suspiciously follow the massive rally in technology stocks as well as the vaccine-driven rebound in value stocks. My dividend income amounted to $3...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG ADR Company Name:
BAYRY Stock Symbol:
OTCMKTS Market:
AlloVir Inc. (ALVR) is expected to report $-0.16 for Q1 2024 Inter & Co. Inc. (INTR) is expected to report $0.08 for Q1 2024 Array Technologies Inc. (ARRY) is expected to report $-0.06 for Q1 2024 Sphere 3D Corp. (ANY) is expected to report $-0.23 for Q1 2024 Alpine Immune Sci...
Carisma Therapeutics Inc. (CARM) is expected to report $-0.56 for Q4 2023 First Acceptance Corp. (FACO) is expected to report for quarter end 2023-12-31 Bell Copper Corp (BCUFF) is expected to report for quarter end 2023-12-31 BioHarvest Sciences Inc (CNVCF) is expected to report for ...